RSC Working Group of Young Cardiologists launched new online service "Rating of young cardiologists"

06.02.20162043
This rating will help to choose the best from young specialists.

В рамках исследования EMPA REG OUTCOME® эмпаглифлозин продемонстрировал превосходство для первичной конечной сердечно-сосудистой точки и значительное снижение сердечно-сосудистой смертности у пациентов с сахарным диабетом 2-го типа

04.02.20160
Эмпаглифлозин - единственный препарат для лечения сахарного диабета 2-го типа, который продемонстрировал снижение риска возникновения сердечно-сосудистых событий и уровня смертности от сердечно-сосудистых заболеваний (ССЗ).

Abstract submission on Anitschkow Days 2016 in St.Petersburg!

29.01.20161757
Symposium of the International Atherosclerosis Society “Anitschkow Days” will be held in St. Petersburg, June 2-4, 2016.

High pulse pressure associated with adverse CV outcomes

29.01.20161911
High pulse pressure confers elevated risk for adverse CV outcomes and enables refinement of prognostication beyond mean arterial pressure, according to new data from the REACH registry.

Low-dose chlorthalidone superior to low-dose hydrochlorothiazide for sustained BP lowering

28.01.20162043
In a new study, low-dose chlorthalidone was associated with further reductions in mean 24-hour BP compared with low-dose hydrochlorothiazide in patients with stage 1 hypertension.

Dabigatran, warfarin comparable for stroke prevention in real-world patients with AF

27.01.20161781
For prevention of ischemic stroke, dabigatran and warfarin were associated with similar outcomes in real-world patients with nonvalvular atrial fibrillation, but dabigatran was associated with increased risk for gastrointestinal bleeding in elderly adults, according to new data published in Circulation: Cardiovascular Quality and Outcomes.

Within the X All-Russian Conference "Womens health problems and its treatment" there would be held a photo exhibition "Go Red For Women®"

26.01.20162643
Go Red For Women® initiative in Russia decided to use this opportunity to attract peoples attention and increase their knowledge about risk factors and causes of cardiovascular disease in women.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.